Patent · US Active

Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

US8268618B2 · kind B2 · utility

1Cited by
46References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 16, 2006
Grant dateSep 18, 2012
Priority date
Expiry dateDec 5, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/85
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.